heart failure semaglutide FDA Clears For Cardiac Risk Reduction in Diabetic Patients Semaglutide in Patients With Obesity
Description
Although this medicine can be helpful for treating diseases such as obesity and type 2 diabetes by lowering a persons glucose levels and promoting weight loss, concern has been raised about a potential unwanted side effect
Nausea is typically most common during dose escalation periods
More information about our supportive treatments can be found on our Wellness page
The reduction in HbA 1c was greater with high-dose sitagliptin/metformin than with either drug alone
None of these windows is a clinical dosing instruction they describe how the compound is scheduled in research
